Stock recommendations - Right stocks at the right time

No more tall claims or frivolous guarantees.
Only quality, long-term growth.

(And get a FREE stock recommendation for signing up!)

Stay on top of your investments

DISCOVER

Deep-dive into lesser-known stocks

INVEST

Get buy calls, at the right time & right price

REVIEW

Receive alerts on booking profits or selling

ADVANTAGE

Get a heads up on stocks in our watchlist

DIY

Use smart filters for DIY investing decisions

What’s on our buy list now?

An FMCG promise

This stock’s potential hinges on FMCG growth, and gets the same ‘defensive’ tag that FMCG does. But, unlike FMCGs, it doesn’t trade at multi-year highs.

A solid NBFC

This company ticks every box – a great customer market, access to low-cost funding, comfortable capital cushion, well-provisioned for potential NPAs, and reasonable valuations

A power play

This stock wins on superior margins, pricing power, and vast retail market access. All this with great valuations and steady dividends providing a moat.

What we offer

Buy/sell/hold recommendations

Looking to buy investment-friendly stocks that come with long-term payoffs? Prime Stocks provides an expertly-curated list of stocks from which you can choose.

We also provide real-time updates on our coverage and when to accumulate, book profits or sell.

DIY stock filters (with download features)

Been in the game long enough to know what you are looking for? Prefer to do your own research? Prime Stocks puts you in the driver’s seat.

Our stock screener tool lets you do your own stock analysis with the right evaluation metrics and data.

Predesigned stock screeners

Want to do your own analysis but don’t quite know where to start? Or looking for unique filters like steady dividend payouts or rising profits or higher FII holding?

Our pre-built screeners give you a great base and it’s easy for you to add on other different filters for a great shortlist.

New stock opportunities

Eager to unearth lesser-known stocks that can turn out to be hidden gems? We dive deep into stock performers and numbers to review lesser-known or up-and-coming stocks.

Our in-depth analysis and data on stocks will keep you two steps ahead and keep you informed on all that’s going on in the world of stocks.

Make each investment take you one step closer to achieving your financial goals

What makes us different

num1

One-stop-shop

with stock recommendations, reviews & filtering tools

num2

Quantitative evaluation

model with advanced metrics to measure stock strength & growth

num3

Qualitative analysis

on shortlisted stocks to pick the best of long-term potential

num4

Rigorous follow-ups

on recommended stocks – hold, book profits or sell at the right time

num5

Feature-rich screener tool

with filters and metrics that aren’t easily available like NPAs or cash flow growth

num6

Downloadable data

on standalone/ consolidated financials, prices, past valuations & more

Why our customers trust us

Maulik Shah
Read More
Brilliant insights. I eagerly wait for alternate days to see new articles from you guys. Really helpful and an eye-opener for DIY investors. Keep up the good work.
Raspreet Singh
Read More
Wow, finally it begins. And begins with a bang. Happy to note the first Prime Stock – excellent choice.
Shakir Mohammad
Read More
Hurray !!! first one being the one from the most valued companies !! Waiting for so long on stocks .. Thank you for the recommendation !! Waiting for more to come!!
Nipun Puri
Nipun Puri
Read More
Thanks a ton for sharing such a good analysis. Great stuff from the team to start sharing long term stock recommendations as well!
Doyal Mukherjee
Read More
I’m 25 years old and I’m very new to stocks and mutual funds, but I liked your explanation as it’s in a very simple language...

Get expertly-curated stock recommendations

Our latest insights

IPO Review: Glenmark Life Sciences – Should you invest?

Glenmark Life Sciences (GLS) is a generic API (Active Pharmaceutical Ingredients) manufacturer and a subsidiary of Glenmark Pharmaceuticals. The Glenmark Life Sciences IPO is worth Rs. 1,514 crore, comprising fresh issue of Rs.1,060 crore and an offer for sale worth Rs.454 crore by Glenmark Pharmaceuticals. Should you invest in the IPO of this high-value, non-commoditized API player?

Premium article available only to subscribers.

Read more

How to evaluate banking and finance stocks

There are certain characteristics which make evaluating banking and finance stocks different from others which produce goods and services. Money cannot be lent to someone unless there is an inflow by way of capital or debt. Since it is not practical to lend only from capital, borrowing (or leverage) is the sustaining food for this business. Naturally in using this leverage, there are good and bad apples.

Premium article available only to subscribers.

Read more

Frequently Asked Questions

Prime Stocks is purely for long-term investors who want to supplement their portfolio of mutual funds, deposits, or ETFs with quality stocks. It is not meant for active stock-only investors who wish to have frequent ‘buy’ or ‘reduce’ calls.

We do not provide any target price for our stocks as we think they are meant for long-term holding. However, in case of any valuations that may be out of sync with growth prospects or other governance or regulatory risks, we will issue a sell call or even ‘book profits’ calls.

We also do not use any technical analysis to pick Prime stocks.

This is not an advisory service. Hence, we will not provide any advice on your stock holdings or
review them.

We will respond only to queries relating to the recommendations in our list. We will not respond to individual stock queries. We also retain the discretion to review stocks that we find worthy and do not cover stocks on your request.

Our filters and screeners are not our recommendations. They are tools meant for your analysis. We do not provide any research on screeners that you run.

We do not guarantee any returns on stocks that we recommend and are not liable for any losses you may incur based on the recommendations.

We do not have any platform to provide any execution service. We also do not manage your money in any form.


Login to your account
OR